PD05-09 improved stone quality of life in patients with obstructing ureteral stone on alpha-blocker medical expulsive therapy
Abstract
INTRODUCTION AND OBJECTIVE: Ureteral stents (US) are commonly used for the treatment of ureteral obstruction, most often urolithiasis. Their use may be associated with signi fi cant bothersome symptoms and discomfort. Prior studies have examined the effects of various medication regimens on ureteral stent symptoms. This study utilized Bayesian network meta-analysis to analyze all available evidence on the pharmacological management of ureteral stent-related symptoms. METHODS: In August 2021 a systematic review was conducted following PRISMA guidelines on randomized prospective studies on pharmacological management of USRS reporting outcomes using the USSQ score on urinary symptoms and pain. Data was analyzed in Review Manager 5.3 and R Studio where a Bayesian network meta-analysis was performed. Treatments were ranked using surface under the cumulative ranking curve(SUCRA) and mean difference(MD) vs placebo with 95% Credible Intervals(CrI). RESULTS: 22 studies were analyzed. These were used to build networks which were modelled to run 100,000 Markov Chain Mon- tecarlo simulations each. Drug-class analysis revealed the most effective class for each domain: for urinary symptoms, sexual performance, general health and work performance - combined Alpha-Blocker & Anticholinergic & PDI; for pain - combined Anticholinergic & Pregabalin. The following were the most effective drugs and dosages for speci fi c symptoms: for urinary symptoms combined Silodosin 8mg þ Solifenacin 10mg; for…
Read the paper
Related studies
- Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study
- Workplace Violence Is Associated With Impaired Work Functioning in Nurses: An Italian Cross-Sectional Study
- Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study
- Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
- Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder
- Association between triglyceride glucose‐body mass index and hypertension in Chinese adults: A cross‐sectional study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.